Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bio-Rad Laboratories Inc Cl B (BIO.B)

Bio-Rad Laboratories Inc Cl B (BIO.B)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bio-Rad Laboratories Inc Cl B 1000 ALFRED NOBEL DR HERCULES CA USA

www.bio-rad.com P: 510-724-7000 F: 510-741-5817

Description:

BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.

Key Statistics

Overview:

Market Capitalization, $K 7,982,471
Enterprise Value, $K 8,778,191
Shares Outstanding, K 28,518
Annual Sales, $ 2,671 M
Annual Net Income, $ -637,320 K
Last Quarter Sales, $ 681,180 K
Last Quarter Net Income, $ 349,710 K
EBIT, $ 337,800 K
EBITDA, $ 337,800 K
60-Month Beta 0.66
% of Insider Shareholders 28.38%
% of Institutional Shareholders 0.01%
Float, K 20,425
% Float 71.62%
Short Volume Ratio 1.00

Growth:

1-Year Return -39.69%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 16.68%
5-Year Earnings Growth 101.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 3.10 on 02/15/24
Latest Earnings Date 05/07/24 [AMC]
Earnings Per Share ttm 11.77
EPS Growth vs. Prev Qtr 33.05%
EPS Growth vs. Prev Year -6.34%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BIO.B Ratios

Ratio
Price/Earnings ttm 28.76
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 3.90%
Return-on-Assets % 2.77%
Profit Margin % -23.86%
Debt/Equity 0.14
Price/Sales 3.61
Price/Cash Flow 23.12
Price/Book 0.91
Book Value/Share 306.49
Interest Coverage -16.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar